Telemedicine for Treatment of Opioid Use Disorder: NIDA Summer Research Internship Program

用于治疗阿片类药物使用障碍的远程医疗：NIDA 夏季研究实习计划

基本信息

批准号：
10402983
负责人：
HAIDEN A. HUSKAMP
金额：
$ 1.06万
依托单位：
HARVARD MEDICAL SCHOOL
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-07-01 至 2023-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10402983
关键词：
Address Adoption Alcohol consumption American Buprenorphine Caring Characteristics Clinical Communities Congresses Data Disease Disease model Drug Addiction Enrollment Epidemic Evaluation Evidence based treatment Goals Growth Health Improve Access Individual Insurance Internet Internships Interview Knowledge Laws Machine Learning Measures Medicaid Medicare Mental disorders Methadone Methods Modeling Naltrexone National Institute of Drug Abuse Patients Persons Pharmaceutical Preparations Play Policies Privacy Provider Quality of Care Recommendation Regulation Research Role Series Speed Structure Substance Use Disorder Telemedicine Time Transportation Treatment Efficacy United States Food and Drug Administration Variant Visit Work base combat design improved improved outcome interest machine learning method methamphetamine use opioid epidemic opioid mortality opioid use disorder physically handicapped programs randomized trial rural area screening summer research treatment duration

项目摘要

PROJECT SUMMARY: A key challenge in combating the opioid epidemic has been connecting individuals with opioid use disorder to evidence-based treatments. The President's Commission on Combating Drug Addiction and the Opioid Crisis and others have suggested that telemedicine for substance use disorder (“tele- SUD”) may be part of the solution. In preliminary analyses, we have found that tele-SUD use is growing rapidly, and there is widespread policy interest in Congress and state legislatures in how to accelerate this growth. The SUPPORT for Patients and Communities Act, signed into law in October 2018, includes several provisions intended to reduce barriers to tele-SUD use and will likely increase the availability of and reimbursement for tele-SUD. However, despite the widespread interest and growing use, there has never been a rigorous assessment of tele-SUD. For example, what are the different tele-SUD models being used to treat opioid use disorder, what barriers exist to greater use of tele-SUD, and is tele-SUD use associated with improved (or potentially worse) quality of care for people with opioid use disorder? To fill this knowledge gap, we propose a comprehensive national evaluation of telemedicine for opioid use disorder using data through 2021 from Medicaid, Medicare, and commercial insurance as well as a series of qualitative interviews. Our Aims are to: (1) describe the different models of how tele-SUD is being incorporated into opioid use disorder care and how this is changing over time, (2) identify regional factors associated with greater tele-SUD use for opioid use disorder, (3) examine the association between tele-SUD use and quality of opioid use disorder care received and whether this varies by model, and (4) describe existing tele-SUD programs, and identify barriers and facilitators to tele-SUD adoption and sustainability. The proposed mixed-methods study will help providers interested in using tele-SUD and inform ongoing debates about regulations and reimbursement for tele-SUD in Congress and state legislatures. Our goal is to highlight policies and practices that drive greater use of tele-SUD and explore its potential role in improving access to, and quality of, care for individuals with opioid use disorder. Our research will help inform how tele- SUD may be leveraged to combat the opioid epidemic as well as other substance use disorders, such as alcohol and methamphetamine use disorders.

项目摘要：抗击阿片类药物流行病的一个关键挑战是将个人联系起来总统禁毒委员会对阿片类药物使用障碍进行循证治疗。成瘾和阿片类药物危机等人建议，针对物质使用障碍的远程医疗（“远程医疗”） SUD”）可能是解决方案的一部分。在初步分析中，我们发现远程 SUD 的使用正在增长。国会和州立法机构对如何加速这一进程存在广泛的政策兴趣 2018 年 10 月签署成为法律的《患者和社区支持法案》包括多项内容。旨在减少远程 SUD 使用障碍的规定，并可能增加然而，尽管人们对远程 SUD 的兴趣广泛且使用不断增加，但从未实现过。对 tele-SUD 的严格评估例如，用于治疗的不同 tele-SUD 模型是什么。阿片类药物使用障碍，更多使用远程 SUD 存在哪些障碍，以及远程 SUD 的使用与改善（或可能恶化）阿片类药物使用障碍患者的护理质量？我们建议使用以下数据对阿片类药物使用障碍的远程医疗进行全面的国家评估： 2021 年来自医疗补助、医疗保险和商业保险以及我们的一系列定性访谈。目的是：(1) 描述如何将远程 SUD 纳入阿片类药物使用障碍的不同模型护理以及这种情况如何随时间变化，(2) 确定与更多使用远程 SUD 相关的区域因素阿片类药物使用障碍，(3) 检查远程 SUD 使用与阿片类药物使用障碍护理质量之间的关联收到的信息以及这是否因型号而异，以及 (4) 描述现有的远程 SUD 计划，并识别障碍以及远程 SUD 采用和可持续性的促进者。拟议的混合方法研究将帮助有兴趣使用远程 SUD 的提供商，并为正在进行的研究提供信息在国会和州立法机构中就远程 SUD 的法规和报销进行辩论我们的目标是强调推动更多地使用远程 SUD 的政策和实践，并探讨其在改善我们的研究将有助于了解如何远程治疗阿片类药物使用障碍患者的护理机会和质量。 SUD 可用于对抗阿片类药物流行以及其他物质使用障碍，例如酒精和甲基苯丙胺使用障碍。

项目成果

期刊论文数量（4）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Adoption of telemedicine services by substance abuse treatment facilities in the U.S.

美国药物滥用治疗机构采用远程医疗服务

DOI：
发表时间：
2020
期刊：
影响因子：
3.9
作者：
Uscher;Cantor, Jonathan;Huskamp, Haiden A;Mehrotra, Ateev;Busch, Alisa;Barnett, Michael
通讯作者：
Barnett, Michael

Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model.

在家中治疗阿片类药物使用障碍患者：一种新兴的治疗模式。

DOI：
发表时间：
2020
期刊：
影响因子：
0
作者：
Uscher;Huskamp, Haiden A;Mehrotra, Ateev
通讯作者：
Mehrotra, Ateev

Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters.

卫生中心针对阿片类药物使用障碍实施远程医疗：对采用者和非采用者的定性评估。

DOI：
发表时间：
2020-08
期刊：
影响因子：
3.9
作者：
Uscher;Raja, Pushpa;Mehrotra, Ateev;Huskamp, Haiden A
通讯作者：
Huskamp, Haiden A

Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences.

接受阿片类药物使用障碍治疗远程医疗服务的患者的观点：用户体验的定性分析。

DOI：
发表时间：
2022-11-01
期刊：
影响因子：
0
作者：
Sousa, Jessica L;Raja, Pushpa;Huskamp, Haiden A;Mehrotra, Ateev;Busch, Alisa B;Barnett, Michael L;Uscher
通讯作者：
Uscher